| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.27 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |